Brief: Valeo Pharma Licenses Canadian Rights to Ametop™ Gel from Alliance Pharma
28/04/2020 12:55
April 28 (Reuters) - Alliance Pharma PLC ALAPH.L :
* VALEO PHARMA INC - ENTERED LICENSING AGREEMENT WITH
ALLIANCE
PHARMA PLC FOR EXCLUSIVE COMMERCIALIZATION RIGHTS TO AMETOP(TM)
GEL
Source text for Eikon: ID:nCNWvN1Mva
Further company coverage: ALAPH.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada